Nanoparticles in medicine: Therapeutic applications and developments

被引：1846

作者：

Zhang, L. ^{[2
,3
]}

Gu, F. X. ^{[2
,3
]}

Chan, J. M. ^{[4
]}

Wang, A. Z. ^{[1
,5
]}

Langer, R. S. ^{[2
,3
]}

Farokhzad, O. C. ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol,Lab Nanomed & Biomat, Boston, MA 02115 USA

[2] MIT, Dept Chem Engn, Cambridge, MA 02139 USA

[3] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA

[4] MIT, Dept Biol, Cambridge, MA USA

[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷 / 05期

关键词：

D O I：

10.1038/sj.clpt.6100400

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities.(1,2) Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.

引用

页码：761 / 769

页数：9

共 49 条

[41] Micellar nanocarriers: Pharmaceutical perspectives [J].

Torchilin, V. P. .

PHARMACEUTICAL RESEARCH, 2007, 24 (01) :1-16

[42] Recent advances with liposomes as pharmaceutical carriers [J].

Torchilin, VP .

NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) :145-160

[43] The emerging nanomedicine landscape [J].

Wagner, Volker ;

Dullaart, Anwyn ;

Bock, Anne-Katrin ;

Zweck, Axel .

NATURE BIOTECHNOLOGY, 2006, 24 (10) :1211-1217

[44] In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model [J].

Wong, Ho Lun ;

Rauth, Andrew Mike ;

Bendayan, Reina ;

Wu, Xiao Yu .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (03) :300-308

[45] Controlling liposome blood clearance by surface-grafted polymers [J].

Woodle, MC .

ADVANCED DRUG DELIVERY REVIEWS, 1998, 32 (1-2) :139-152

[46]

Wosikowski K, 2003, CLIN CANCER RES, V9, P1917

[47] Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice [J].

Xie, Yue-Ling ;

Lu, Wei ;

Jiang, Xin-Guo .

BEHAVIOURAL BRAIN RESEARCH, 2006, 173 (01) :76-84

[48] How to stabilize phospholipid liposomes (using nanoparticles) [J].

Zhang, LF ;

Granick, S .

NANO LETTERS, 2006, 6 (04) :694-698

[49] Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates [J].

Zhang, Liangfang ;

Radovic-Moreno, Aleksandar F. ;

Alexis, Frank ;

Gu, Frank X. ;

Basto, Pamela A. ;

Bagalkot, Vaishali ;

Jon, Sangyong ;

Langer, Robert S. ;

Farokhzad, Omid C. .

CHEMMEDCHEM, 2007, 2 (09) :1268-1271

← 1 2 3 4 5 →